FAMOSAN 20 mg Slovakia - Tiếng Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

famosan 20 mg

pro.med.cs praha a.s., Česká republika - famotidín - 09 - antacida (vrÁtane antiulcerosnych lieČiv)

RANITAL 50 mg/2 ml Slovakia - Tiếng Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ranital 50 mg/2 ml

sandoz pharmaceuticals d.d., slovinsko - ranitidín - 09 - antacida (vrÁtane antiulcerosnych lieČiv)

RANITAL 150 mg Slovakia - Tiếng Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ranital 150 mg

sandoz pharmaceuticals d.d., slovinsko - ranitidín - 09 - antacida (vrÁtane antiulcerosnych lieČiv)

Famotidin 20-SL Slovakia - Tiếng Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

famotidin 20-sl

zentiva a.s., slovensko - famotidín - 09 - antacida (vrÁtane antiulcerosnych lieČiv)

Ranitidine Accord 150 mg filmom obalené tablety Slovakia - Tiếng Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ranitidine accord 150 mg filmom obalené tablety

accord healthcare polska sp. z o.o., poľsko - ranitidín - 09 - antacida (vrÁtane antiulcerosnych lieČiv)

Ranitidine Accord 300 mg filmom obalené tablety Slovakia - Tiếng Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ranitidine accord 300 mg filmom obalené tablety

accord healthcare polska sp. z o.o., poľsko - ranitidín - 09 - antacida (vrÁtane antiulcerosnych lieČiv)

FAMOSAN 40 mg Slovakia - Tiếng Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

famosan 40 mg

pro.med.cs praha a.s., Česká republika - famotidín - 09 - antacida (vrÁtane antiulcerosnych lieČiv)

Tagrisso Liên Minh Châu Âu - Tiếng Slovak - EMA (European Medicines Agency)

tagrisso

astrazeneca ab - osimertinib mesilate - karcinóm, pľúc bez malých buniek - iné antineoplastické činidlá, protein kinase inhibítory - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.

SPORANOX Slovakia - Tiếng Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sporanox

johnson & johnson, s.r.o., slovensko - itrakonazol - 26 - antimycotica (lokÁlne a celkovÉ)

WARFARIN ORION 3 mg Slovakia - Tiếng Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

warfarin orion 3 mg

orion corporation, fínsko - warfarín - 16 - anticoagulantia (fibrinolytica, antifibrinol.)